RB
GILD icon

Rodgers Brothers’s Gilead Sciences GILD Stock Holding History

Rodgers Brothers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$497K Hold
3,563
– – 0.06% 179
2025
Q4 		$437K Hold
3,563
– – 0.05% 187
2025
Q3 		$395K Hold
3,563
– – 0.05% 195
2025
Q2 		$395K Sell
3,563
-125
-3% -$13.3K 0.05% 196
2025
Q1 		$413K Hold
3,688
– – 0.06% 188
2024
Q4 		$341K Sell
3,688
-70
-2% -$6.3K 0.04% 198
2024
Q3 		$315K Hold
3,758
– – 0.04% 206
2024
Q2 		$258K Buy
3,758
+20
+0.5% +$1.33K 0.03% 213
2024
Q1 		$274K Hold
3,738
– – 0.04% 216
2023
Q4 		$303K Sell
3,738
-300
-7% -$23.3K 0.05% 200
2023
Q3 		$303K Buy
4,038
+925
+30% +$71.1K 0.05% 187
2023
Q2 		$240K Buy
3,113
+138
+5% +$11K 0.04% 194
2023
Q1 		$247K Hold
2,975
– – 0.05% 189
2022
Q4 		$255K Sell
2,975
-23,850
-89% -$1.89M 0.05% 186
2022
Q3 		$1.66M Sell
26,825
-1,400
-5% -$88.3K 0.35% 79
2022
Q2 		$1.75M Sell
28,225
-200
-0.7% -$12.4K 0.34% 78
2022
Q1 		$1.69M Sell
28,425
-700
-2% -$44.7K 0.3% 81
2021
Q4 		$2.12M Buy
29,125
+100
+0.3% +$6.89K 0.38% 67
2021
Q3 		$2.03M Buy
29,025
+200
+0.7% +$14.1K 0.4% 71
2021
Q2 		$1.99M Buy
28,825
+19,150
+198% +$1.28M 0.38% 71
2021
Q1 		$625K Hold
9,675
– – 0.13% 140
2020
Q4 		$564K Sell
9,675
-2,450
-20% -$148K 0.13% 135
2020
Q3 		$766K Buy
12,125
+8,750
+259% +$607K 0.2% 114
2020
Q2 		$260K Sell
3,375
-1,000
-23% -$76.6K 0.07% 175
2020
Q1 		$327K Sell
4,375
-19,975
-82% -$1.38M 0.1% 152
2019
Q4 		$1.58M Buy
24,350
+3,800
+18% +$247K 0.41% 64
2019
Q3 		$1.3M Hold
20,550
– – 0.36% 72
2019
Q2 		$1.39M Buy
20,550
+150
+0.7% +$9.87K 0.39% 69
2019
Q1 		$1.33M Buy
20,400
+5,575
+38% +$371K 0.38% 65
2018
Q4 		$927K Sell
14,825
-1,550
-9% -$108K 0.3% 78
2018
Q3 		$1.26M Buy
16,375
+375
+2% +$28.3K 0.36% 64
2018
Q2 		$1.13M Sell
16,000
-150
-0.9% -$10.6K 0.35% 68
2018
Q1 		$1.22M Buy
16,150
+3,300
+26% +$262K 0.4% 62
2017
Q4 		$921K Buy
12,850
+1,000
+8% +$75.9K 0.3% 69
2017
Q3 		$960K Buy
11,850
+375
+3% +$28.7K 0.34% 65
2017
Q2 		$812K Hold
11,475
– – 0.3% 71
2017
Q1 		$779K Buy
11,475
+3,200
+39% +$225K 0.29% 73
2016
Q4 		$593K Sell
8,275
-2,055
-20% -$153K 0.23% 88
2016
Q3 		$817K Buy
10,330
+4,800
+87% +$390K 0.33% 72
2016
Q2 		$461K Buy
5,530
+1,500
+37% +$133K 0.19% 100
2016
Q1 		$370K Buy
4,030
+300
+8% +$27.1K 0.16% 109
2015
Q4 		$377K Hold
3,730
– – 0.18% 101
2015
Q3 		$366K Buy
3,730
+1,030
+38% +$114K 0.18% 101
2015
Q2 		$316K Hold
2,700
– – 0.15% 115
2015
Q1 		$265K Buy
2,700
+200
+8% +$20.3K 0.13% 129
2014
Q4 		$236K Hold
2,500
– – 0.12% 134
2014
Q3 		$266K Sell
2,500
-100
-4% -$9.79K 0.14% 120
2014
Q2 		$216K Buy
+2,600
New +$202K 0.11% 139

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Rodgers Brothers's GILD Position: Q1 2026 in Review

Rodgers Brothers held its Gilead Sciences (GILD) position steady in Q1 2026 at 3,563 shares worth $497K. The position accounts for 0.06% of the portfolio, ranked #179.

Rodgers Brothers first reported a position in GILD in Q2 2014 and has held it in 48 quarters since. The position peaked at $2.12M in Q4 2021. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Rodgers Brothers held 3,563 shares of Gilead Sciences worth $497K as of Q1 2026.
  • Rodgers Brothers left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.06% of Rodgers Brothers's portfolio in Q1 2026, its #179 holding.
  • Rodgers Brothers first reported a position in Gilead Sciences in Q2 2014 and has held it in 48 quarters since.
  • Rodgers Brothers's Gilead Sciences position peaked at $2.12M in Q4 2021.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Rodgers Brothers's 13F filing for Q1 2026, filed 14 May 2026.